IT1217190B - USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS - Google Patents

USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS

Info

Publication number
IT1217190B
IT1217190B IT20299/88A IT2029988A IT1217190B IT 1217190 B IT1217190 B IT 1217190B IT 20299/88 A IT20299/88 A IT 20299/88A IT 2029988 A IT2029988 A IT 2029988A IT 1217190 B IT1217190 B IT 1217190B
Authority
IT
Italy
Prior art keywords
hurry
dysfunctions
diagnosis
treatment
useful compounds
Prior art date
Application number
IT20299/88A
Other languages
Italian (it)
Other versions
IT8820299A0 (en
Inventor
Ralf Ruffmann
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of IT8820299A0 publication Critical patent/IT8820299A0/en
Priority to IT20299/88A priority Critical patent/IT1217190B/en
Priority to IL89952A priority patent/IL89952A0/en
Priority to EP89904810A priority patent/EP0374210A1/en
Priority to AU34382/89A priority patent/AU3438289A/en
Priority to JP1504483A priority patent/JPH02504146A/en
Priority to HU892651A priority patent/HU202754B/en
Priority to PCT/EP1989/000417 priority patent/WO1989010123A1/en
Priority to KR1019890702417A priority patent/KR900700098A/en
Priority to ZA892911A priority patent/ZA892911B/en
Priority to DK644589A priority patent/DK644589D0/en
Application granted granted Critical
Publication of IT1217190B publication Critical patent/IT1217190B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT20299/88A 1988-04-22 1988-04-22 USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS IT1217190B (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT20299/88A IT1217190B (en) 1988-04-22 1988-04-22 USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS
IL89952A IL89952A0 (en) 1988-04-22 1989-04-13 Pharmaceutical compositions for the treatment and diagnosis of erectile dysfunctions containing flavone derivatives
JP1504483A JPH02504146A (en) 1988-04-22 1989-04-19 Flavoxate and derivatives for erectile dysfunction
AU34382/89A AU3438289A (en) 1988-04-22 1989-04-19 Flevoxate and derivatives for erectile dysfunctions
EP89904810A EP0374210A1 (en) 1988-04-22 1989-04-19 Flevoxate and derivatives for erectile dysfunctions
HU892651A HU202754B (en) 1988-04-22 1989-04-19 Process for producing flavoxate derivatives and pharmaceutical compositions containing them as active components
PCT/EP1989/000417 WO1989010123A1 (en) 1988-04-22 1989-04-19 Flevoxate and derivatives for erectile dysfunctions
KR1019890702417A KR900700098A (en) 1988-04-22 1989-04-19 Plaboxate and its derivatives for the treatment and diagnosis of erectile dysfunction
ZA892911A ZA892911B (en) 1988-04-22 1989-04-20 Compounds useful in the treatment and diagnosis of erectile dysfunctions
DK644589A DK644589D0 (en) 1988-04-22 1989-12-19 FLAVOXATE AND DERIVATIVES THEREOF TO ERECTILE INTERFERENCES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20299/88A IT1217190B (en) 1988-04-22 1988-04-22 USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS

Publications (2)

Publication Number Publication Date
IT8820299A0 IT8820299A0 (en) 1988-04-22
IT1217190B true IT1217190B (en) 1990-03-14

Family

ID=11165532

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20299/88A IT1217190B (en) 1988-04-22 1988-04-22 USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS

Country Status (8)

Country Link
EP (1) EP0374210A1 (en)
JP (1) JPH02504146A (en)
KR (1) KR900700098A (en)
AU (1) AU3438289A (en)
HU (1) HU202754B (en)
IT (1) IT1217190B (en)
WO (1) WO1989010123A1 (en)
ZA (1) ZA892911B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
BR9709230A (en) * 1996-05-10 1999-08-10 Icos Corp Compound
US6821978B2 (en) 2000-09-19 2004-11-23 Schering Corporation Xanthine phosphodiesterase V inhibitors
WO2003042216A1 (en) 2001-11-09 2003-05-22 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
WO2011023287A1 (en) * 2009-08-27 2011-03-03 Merck Patent Gmbh Use of faa and its derivatives in cosmetics and dermatology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent

Also Published As

Publication number Publication date
KR900700098A (en) 1990-08-11
HU202754B (en) 1991-04-29
IT8820299A0 (en) 1988-04-22
AU3438289A (en) 1989-11-24
EP0374210A1 (en) 1990-06-27
JPH02504146A (en) 1990-11-29
HU892651D0 (en) 1990-11-28
HUT53804A (en) 1990-12-28
WO1989010123A1 (en) 1989-11-02
ZA892911B (en) 1989-12-27

Similar Documents

Publication Publication Date Title
TR26802A (en) The use of h-2 antagonists for the treatment of gingivitis
DK709288D0 (en) HIS UNKNOWN RELATIONSHIPS
DK691488D0 (en) HIS UNKNOWN RELATIONSHIPS
DK673087D0 (en) BENZOXAZINYL AND BENZOTHIAZINYLPYRIDAZINON COMPOUNDS
DK220588A (en) HIS UNKNOWN RELATIONSHIPS
DK321088D0 (en) HIS UNKNOWN RELATIONSHIPS
DK123891A (en) VIBRATOR
IT1217190B (en) USEFUL COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF HURRY DYSFUNCTIONS
DK177889D0 (en) HIS UNKNOWN RELATIONSHIPS
DK286289A (en) HIS UNKNOWN RELATIONSHIPS
DK4689D0 (en) BIOSENSOR
DK359888D0 (en) HIS UNKNOWN RELATIONSHIPS
FI93410B (en) Controlled vibrator
DK578088D0 (en) HIS UNKNOWN RELATIONSHIPS
DK702588D0 (en) HIS UNKNOWN RELATIONSHIPS
DK191089D0 (en) BIOLOGICAL ACTIVE RELATIONS
DK177989D0 (en) HIS UNKNOWN RELATIONSHIPS
IT8967717A0 (en) SURFACE TREATMENT
DK279489D0 (en) HIS UNKNOWN RELATIONSHIPS
DK203089D0 (en) HIS UNKNOWN RELATIONSHIPS
DK709388D0 (en) HIS UNKNOWN RELATIONSHIPS
DK161989D0 (en) HIS UNKNOWN RELATIONSHIPS
DK184789D0 (en) HIS UNKNOWN RELATIONSHIPS
FR2642783B1 (en) EASILY REMOVABLE FLOOR
DE3577985D1 (en) ORGANOTITANIC COMPOUNDS AND SURFACE TREATMENT AGENTS.